Ginkgo Bioworks Holdings Stock Analysis

DNA Stock  USD 8.01  0.30  3.61%   
Ginkgo Bioworks Holdings is overvalued with Real Value of 5.98 and Target Price of 4.21. The main objective of Ginkgo Bioworks stock analysis is to determine its intrinsic value, which is an estimate of what Ginkgo Bioworks Holdings is worth, separate from its market price. There are two main types of Ginkgo Bioworks' stock analysis: fundamental analysis and technical analysis.
The Ginkgo Bioworks stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Ginkgo Bioworks' ongoing operational relationships across important fundamental and technical indicators.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Ginkgo Bioworks Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Ginkgo Stock Analysis Notes

About 64.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.53. Some equities with similar Price to Book (P/B) outperform the market in the long run. Ginkgo Bioworks Holdings recorded a loss per share of 18.0. The entity had not issued any dividends in recent years. The firm had 1:40 split on the 20th of August 2024. Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts. Ginkgo Bioworks operates under Biotechnology classification in the United States and is traded on New York Stock Exchange. It employs 641 people. To learn more about Ginkgo Bioworks Holdings call Jason Kelly at 877 422 5362 or check out https://www.ginkgobioworks.com.

Ginkgo Bioworks Quarterly Total Revenue

56.21 Million

Ginkgo Bioworks Holdings Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Ginkgo Bioworks' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Ginkgo Bioworks Holdings or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Ginkgo Bioworks generated a negative expected return over the last 90 days
Ginkgo Bioworks has high historical volatility and very poor performance
Ginkgo Bioworks has high likelihood to experience some financial distress in the next 2 years
The company reported the last year's revenue of 251.46 M. Reported Net Loss for the year was (892.87 M) with profit before taxes, overhead, and interest of 273.49 M.
Ginkgo Bioworks Holdings has about 1.32 B in cash with (295.5 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.84.
Roughly 64.0% of the company shares are held by institutions such as insurance companies
Latest headline from nypost.com: 23andMe board resigns in feud over CEO Anne Wojcickis plan to take company private

Ginkgo Bioworks Holdings Upcoming and Recent Events

Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Ginkgo Bioworks previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
6th of March 2024
Upcoming Quarterly Report
View
8th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
6th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Ginkgo Largest EPS Surprises

Earnings surprises can significantly impact Ginkgo Bioworks' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-02-29
2023-12-31-0.1-0.11-0.0110 
2023-08-09
2023-06-30-0.08-0.09-0.0112 
2023-05-10
2023-03-31-0.09-0.11-0.0222 
View All Earnings Estimates

Ginkgo Bioworks Environmental, Social, and Governance (ESG) Scores

Ginkgo Bioworks' ESG score is a quantitative measure that evaluates Ginkgo Bioworks' performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Ginkgo Bioworks' operations that may have significant financial implications and affect Ginkgo Bioworks' stock price as well as guide investors towards more socially responsible investments.

Ginkgo Bioworks Thematic Classifications

In addition to having Ginkgo Bioworks stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Biotech Idea
Biotech
Biotechnology and pharmaceuticals production and services

Ginkgo Stock Institutional Investors

Shares
D. E. Shaw & Co Lp2024-06-30
17.4 M
Norges Bank2024-06-30
15.6 M
Qube Research & Technologies2024-06-30
15.5 M
Geode Capital Management, Llc2024-06-30
15.3 M
Aqr Capital Management Llc2024-06-30
10.4 M
State Street Corp2024-06-30
10.1 M
Exor Investments (uk) Llp2024-03-31
10 M
Monaco Asset Management2024-06-30
9.8 M
Welch & Forbes Llc2024-06-30
7.3 M
Viking Global Investors Lp2024-06-30
143.1 M
Vanguard Group Inc2024-06-30
139 M
Note, although Ginkgo Bioworks' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Ginkgo Market Capitalization

The company currently falls under 'Small-Cap' category with a total capitalization of 445.16 M.

Ginkgo Profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(0.58)(0.61)
Return On Capital Employed(0.45)(0.47)
Return On Assets(0.54)(0.56)
Return On Equity(0.81)(0.85)

Management Efficiency

Ginkgo Bioworks Holdings has Return on Asset of (0.223) % which means that on every $100 spent on assets, it lost $0.223. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.7683) %, meaning that it generated no profit with money invested by stockholders. Ginkgo Bioworks' management efficiency ratios could be used to measure how well Ginkgo Bioworks manages its routine affairs as well as how well it operates its assets and liabilities. As of September 22, 2024, Return On Tangible Assets is expected to decline to -0.61. In addition to that, Return On Capital Employed is expected to decline to -0.47. At present, Ginkgo Bioworks' Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 107.1 M, whereas Net Tangible Assets are forecasted to decline to about 1.1 B.
Last ReportedProjected for Next Year
Book Value Per Share 22.57  17.71 
Tangible Book Value Per Share 19.86  16.42 
Enterprise Value Over EBITDA(4.29)(4.51)
Price Book Value Ratio 3.00  2.85 
Enterprise Value Multiple(4.29)(4.51)
Price Fair Value 3.00  2.85 
Enterprise Value2.6 B2.5 B
The analysis of Ginkgo Bioworks' management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Ginkgo Bioworks' future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Ginkgo Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Operating Margin
(2.74)
Beta
1.069
Return On Assets
(0.22)
Return On Equity
(0.77)

Technical Drivers

As of the 22nd of September, Ginkgo Bioworks retains the Standard Deviation of 8.19, risk adjusted performance of (0.07), and Market Risk Adjusted Performance of (0.20). Ginkgo Bioworks technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

Ginkgo Bioworks Holdings Price Movement Analysis

Execute Study
The output start index for this execution was thirty-five with a total number of output elements of twenty-six. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Ginkgo Bioworks middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Ginkgo Bioworks Holdings. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Ginkgo Bioworks Holdings Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Ginkgo Bioworks insiders, such as employees or executives, is commonly permitted as long as it does not rely on Ginkgo Bioworks' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Ginkgo Bioworks insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Ginkgo Bioworks Outstanding Bonds

Ginkgo Bioworks issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Ginkgo Bioworks Holdings uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Ginkgo bonds can be classified according to their maturity, which is the date when Ginkgo Bioworks Holdings has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Ginkgo Bioworks Predictive Daily Indicators

Ginkgo Bioworks intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Ginkgo Bioworks stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Ginkgo Bioworks Corporate Filings

F4
16th of September 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
12th of September 2024
Other Reports
ViewVerify
8K
4th of September 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
8K
19th of August 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
8K
15th of August 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
12th of August 2024
Other Reports
ViewVerify
8K
8th of August 2024
An amendment to a previously filed Form 8-K
ViewVerify
F4
6th of August 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify

Ginkgo Bioworks Forecast Models

Ginkgo Bioworks' time-series forecasting models are one of many Ginkgo Bioworks' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Ginkgo Bioworks' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Ginkgo Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Ginkgo Bioworks prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Ginkgo shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Ginkgo Bioworks. By using and applying Ginkgo Stock analysis, traders can create a robust methodology for identifying Ginkgo entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(3.55)(3.73)
Operating Profit Margin(2.67)(2.81)
Net Loss(3.55)(3.73)
Gross Profit Margin 0.57  0.69 

Current Ginkgo Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Ginkgo analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Ginkgo analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
4.21Hold6Odds
Ginkgo Bioworks Holdings current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Ginkgo analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Ginkgo stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Ginkgo Bioworks Holdings, talking to its executives and customers, or listening to Ginkgo conference calls.
Ginkgo Analyst Advice Details

Ginkgo Stock Analysis Indicators

Ginkgo Bioworks Holdings stock analysis indicators help investors evaluate how Ginkgo Bioworks stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Ginkgo Bioworks shares will generate the highest return on investment. By understating and applying Ginkgo Bioworks stock analysis, traders can identify Ginkgo Bioworks position entry and exit signals to maximize returns.
Begin Period Cash Flow1.3 B
Common Stock Shares Outstanding48.6 M
Total Stockholder Equity1.1 B
Tax Provision-14.6 M
Property Plant And Equipment Net397.2 M
Cash And Short Term Investments948.9 M
Cash948.9 M
Accounts Payable9.3 M
Net Debt-707.1 M
50 Day M A9.7358
Total Current Liabilities163.9 M
Other Operating Expenses923.7 M
Non Current Assets Total663.6 M
Non Currrent Assets Other1.5 M
Stock Based Compensation229.9 M

Complementary Tools for Ginkgo Stock analysis

When running Ginkgo Bioworks' price analysis, check to measure Ginkgo Bioworks' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ginkgo Bioworks is operating at the current time. Most of Ginkgo Bioworks' value examination focuses on studying past and present price action to predict the probability of Ginkgo Bioworks' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ginkgo Bioworks' price. Additionally, you may evaluate how the addition of Ginkgo Bioworks to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Global Correlations
Find global opportunities by holding instruments from different markets
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.